Recombinant trivalent rotavirus subunit vaccine (MaxHealth)

重组三价轮状病毒亚单位疫苗（迈科康）

Report date: 2026/03/17 20:00:15

Base Information

Drug NameRecombinant trivalent rotavirus subunit vaccine (MaxHealth)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastroenteritisRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMaxvax Biotechnology LLC
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Maikekang Biological Technology Co LtdMaxvax Biotechnology LLC
Inactive CompaniesN/A
Active IndicationsGastroenteritisRotavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A